Total Payments
$8,734
2024 Payments
$624.74
Companies
33
Transactions
558
Medicare Patients
2,810
Medicare Billing
$411,284
Payment Breakdown by Category
Food & Beverage$8,692 (99.5%)
Education$41.82 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,692 | 556 | 99.5% |
| Education | $41.82 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,856 | 190 | $0 (2024) |
| Genentech USA, Inc. | $1,118 | 82 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $819.94 | 63 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $696.64 | 36 | $0 (2024) |
| Mylan Specialty L.P. | $269.87 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $269.10 | 21 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $263.50 | 15 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $254.33 | 25 | $0 (2019) |
| Grifols USA, LLC | $239.57 | 12 | $0 (2024) |
| Electromed, Inc. | $209.94 | 15 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $624.74 | 30 | GlaxoSmithKline, LLC. ($199.63) |
| 2023 | $1,126 | 55 | GlaxoSmithKline, LLC. ($379.87) |
| 2022 | $978.11 | 51 | GlaxoSmithKline, LLC. ($273.16) |
| 2021 | $920.35 | 57 | GlaxoSmithKline, LLC. ($329.94) |
| 2020 | $703.18 | 35 | GlaxoSmithKline, LLC. ($313.81) |
| 2019 | $1,414 | 88 | GlaxoSmithKline, LLC. ($411.33) |
| 2018 | $1,453 | 121 | GlaxoSmithKline, LLC. ($514.45) |
| 2017 | $1,514 | 121 | GlaxoSmithKline, LLC. ($433.91) |
All Payment Transactions
558 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Vaccines | ||||||
| 07/01/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $25.47 | General |
| 05/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/29/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 03/26/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Pulmonology | ||||||
| 03/25/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $25.59 | General |
| Category: Medical Device | ||||||
| 03/14/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Immunology | ||||||
| 03/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 02/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Immunology | ||||||
| 02/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: RESPIRATORY | ||||||
| 02/12/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 02/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Immunology | ||||||
| 02/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Pulmonology | ||||||
| 02/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 01/31/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 01/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: RESPIRATORY | ||||||
| 01/14/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 350 | 638 | $187,083 | $64,953 |
| 2022 | 10 | 605 | 1,042 | $266,145 | $94,923 |
| 2021 | 14 | 770 | 1,299 | $339,475 | $122,550 |
| 2020 | 19 | 1,085 | 1,698 | $349,186 | $128,859 |
Total Patients
2,810
Total Services
4,677
Medicare Billing
$411,284
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 78 | 229 | $117,471 | $36,678 | 31.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 63 | 118 | $27,424 | $10,437 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 66 | 112 | $15,926 | $7,393 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 80 | 103 | $8,658 | $4,391 | 50.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 24 | $9,516 | $3,055 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 52 | $8,088 | $2,999 | 37.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 76 | 210 | $107,310 | $35,234 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 145 | 366 | $49,044 | $19,794 | 40.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 70 | 137 | $26,441 | $10,711 | 40.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 60 | $22,560 | $9,062 | 40.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 61 | 62 | $22,196 | $5,793 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 51 | 59 | $8,728 | $4,429 | 50.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 37 | 38 | $9,728 | $3,732 | 38.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 30 | 30 | $10,350 | $2,711 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 51 | 52 | $4,888 | $2,558 | 52.3% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Facility | 2022 | 28 | 28 | $4,900 | $898.82 | 18.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 102 | 320 | $163,520 | $54,208 | 33.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 110 | 244 | $47,092 | $19,425 | 41.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 133 | 285 | $38,190 | $15,695 | 41.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 74 | 75 | $28,200 | $11,417 | 40.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 62 | 75 | $11,178 | $5,449 | 48.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 74 | 81 | $7,614 | $3,823 | 50.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 33 | 35 | $8,960 | $3,608 | 40.3% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 37 | 37 | $12,765 | $3,325 | 26.0% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Facility | 2021 | 34 | 35 | $12,530 | $3,041 | 24.3% |
About Dr. Gregory Stark, MD
Dr. Gregory Stark, MD is a Pulmonary Disease healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962500967.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Stark, MD has received a total of $8,734 in payments from pharmaceutical and medical device companies, with $624.74 received in 2024. These payments were reported across 558 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,692).
As a Medicare-enrolled provider, Stark has provided services to 2,810 Medicare beneficiaries, totaling 4,677 services with total Medicare billing of $411,284. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Ashland, KY
- Active Since 09/21/2006
- Last Updated 11/07/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1962500967
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,482
- Xolair (Biological) $979.01
- NUCALA (Biological) $613.71
- OFEV (Drug) $540.99
- XOLAIR (Biological) $470.14
- GLASSIA (Biological) $345.17
- BREO (Drug) $319.59
- ANORO (Drug) $276.26
- XOLAIR (Drug) $226.50
- SMARTVEST (Device) $209.94
- Yupelri (Drug) $203.35
- UPTRAVI (Drug) $201.97
- DUPIXENT (Biological) $184.11
- Prolastin-C Liquid (Biological) $156.48
- Esbriet (Biological) $124.85
- STIOLTO (Drug) $123.09
- LONHALA MAGNAIR (Drug) $119.62
- TYVASO (Drug) $117.88
- XARELTO (Drug) $114.17
- Utibron (Drug) $101.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Ashland
Scott Nelson, Md, MD
Pulmonary Disease — Payments: $12,158
Pulmonary Disease $12,158
Bjorn Thorarinsson, Md, MD
Pulmonary Disease — Payments: $6,798
Pulmonary Disease $6,798
Chelsey White, D.o, D.O
Pulmonary Disease — Payments: $6,707
Pulmonary Disease $6,707
James Powell, Md, MD
Pulmonary Disease
Pulmonary Disease